Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q39995934)
Watch
English
Blocking the survival of the nastiest by HSP90 inhibition
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
title
Blocking the survival of the nastiest by HSP90 inhibition
(English)
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
author
Bissan Al-Lazikani
object named as
Bissan Al-Lazikani
series ordinal
3
0 references
Paul Workman
series ordinal
1
object named as
Paul Workman
1 reference
stated in
Europe PubMed Central
retrieved
16 September 2017
PMCID
4826159
author name string
Paul A Clarke
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
language of work or name
English
0 references
publication date
1 January 2016
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
published in
Oncotarget
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
volume
7
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
issue
4
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
page(s)
3658-3661
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
cites work
HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4826159
retrieved
22 September 2017
Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma models
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4826159
retrieved
22 September 2017
Cancer: evolution within a lifetime
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4826159
retrieved
22 September 2017
Combinatorial drug therapy for cancer in the post-genomic era.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4826159
retrieved
22 September 2017
Clonal evolution in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4826159
retrieved
22 September 2017
Hsp90 molecular chaperone inhibitors: are we there yet?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4826159
retrieved
22 September 2017
The clonal evolution of tumor cell populations
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4826159
retrieved
22 September 2017
Identifiers
DOI
10.18632/ONCOTARGET.6971
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
PMCID
4826159
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
PubMed ID
26820296
1 reference
stated in
Europe PubMed Central
PMCID
4826159
retrieved
16 September 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
